Published in J Neurosurg on December 01, 1995
Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomaterials (2007) 3.12
Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells. J Transl Med (2008) 1.54
High intratumoural accumulation of stealth liposomal doxorubicin (Caelyx) in glioblastomas and in metastatic brain tumours. Br J Cancer (2000) 1.18
Multiple treatments with liposomal doxorubicin and ultrasound-induced disruption of blood-tumor and blood-brain barriers improve outcomes in a rat glioma model. J Control Release (2013) 1.12
A novel peptide enhances therapeutic efficacy of liposomal anti-cancer drugs in mice models of human lung cancer. PLoS One (2009) 1.10
Biomaterials for the central nervous system. J R Soc Interface (2008) 1.08
Multifunctional nanoparticles for brain tumor imaging and therapy. Adv Drug Deliv Rev (2013) 1.07
Mind the gap: a survey of how cancer drug carriers are susceptible to the gap between research and practice. J Control Release (2013) 1.06
Nanodrug delivery in reversing multidrug resistance in cancer cells. Front Pharmacol (2014) 1.05
Effect of repetitive administration of Doxorubicin-containing liposomes on plasma pharmacokinetics and drug biodistribution in a rat brain tumor model. Clin Cancer Res (2005) 1.01
Quantification of Doxorubicin and metabolites in rat plasma and small volume tissue samples by liquid chromatography/electrospray tandem mass spectroscopy. J Chromatogr B Analyt Technol Biomed Life Sci (2004) 0.99
Recent progress towards development of effective systemic chemotherapy for the treatment of malignant brain tumors. J Transl Med (2009) 0.95
Halofuginone inhibits angiogenesis and growth in implanted metastatic rat brain tumor model--an MRI study. Neoplasia (2004) 0.95
Identifying new small molecule anti-invasive compounds for glioma treatment. Cell Cycle (2013) 0.94
Phase 2 study of temozolomide and Caelyx in patients with recurrent glioblastoma multiforme. Neuro Oncol (2004) 0.92
Application of nanoparticles on diagnosis and therapy in gliomas. Biomed Res Int (2013) 0.91
Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101). PLoS One (2014) 0.91
Nanoparticles for imaging and treating brain cancer. Nanomedicine (Lond) (2013) 0.90
Pharmacokinetics and efficacy of PEGylated liposomal doxorubicin in an intracranial model of breast cancer. PLoS One (2013) 0.89
Multiple sessions of liposomal doxorubicin delivery via focused ultrasound mediated blood-brain barrier disruption: a safety study. J Control Release (2015) 0.88
RNOP-09: pegylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma--a phase II study. BMC Cancer (2009) 0.87
Biodistribution and pharmacokinetics of 111In-DTPA-labelled pegylated liposomes in a human tumour xenograft model: implications for novel targeting strategies. Br J Cancer (2000) 0.86
Age-stratified phase I trial of a combination of bortezomib, gemcitabine, and liposomal doxorubicin in patients with advanced malignancies. Cancer Chemother Pharmacol (2011) 0.84
Drug conjugates such as Antibody Drug Conjugates (ADCs), immunotoxins and immunoliposomes challenge daily clinical practice. Int J Mol Sci (2012) 0.83
Fabrication principles and their contribution to the superior in vivo therapeutic efficacy of nano-liposomes remote loaded with glucocorticoids. PLoS One (2011) 0.82
Nano to micro delivery systems: targeting angiogenesis in brain tumors. J Angiogenes Res (2010) 0.82
Novel asparagine-derived lipid enhances distearoylphosphatidylcholine bilayer resistance to acidic conditions. Langmuir (2011) 0.80
Reinduction of bevacizumab in combination with pegylated liposomal Doxorubicin in a patient with recurrent glioblastoma multiforme who progressed on bevacizumab/irinotecan. J Oncol (2008) 0.79
Overcoming the challenges in the effective delivery of chemotherapies to CNS solid tumors. Ther Deliv (2010) 0.78
The effects of nanoparticle drug loading on the pharmacokinetics of anticancer agents. Nanomedicine (Lond) (2015) 0.75
Pegylated liposomal Doxorubicin-induced acute transient encephalopathy in a patient with breast cancer: a case report. Case Rep Oncol (2014) 0.75
Pharmacokinetics, antitumor and cardioprotective effects of liposome-encapsulated phenylaminoethyl selenide in human prostate cancer rodent models. Pharm Res (2014) 0.75
Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancer. Cancer Chemother Pharmacol (2017) 0.75
Efficacy and pharmacokinetics of a modified acid-labile docetaxel-PRINT(®) nanoparticle formulation against non-small-cell lung cancer brain metastases. Nanomedicine (Lond) (2016) 0.75
Therapeutic Efficacy of Orally Delivered Doxorubicin Nanoparticles in Rat Tongue Cancer Induced by 4-Nitroquinoline 1-Oxide. Adv Pharm Bull (2015) 0.75
Nanotechnology Applications for Diffuse Intrinsic Pontine Glioma. Curr Neuropharmacol (2016) 0.75
Dehalogenation: a novel pathway for the anaerobic biodegradation of haloaromatic compounds. Science (1982) 6.79
Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci U S A (1991) 4.85
Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times. Biochim Biophys Acta (1991) 2.08
Mapping of N6-methyladenosine residues in bovine prolactin mRNA. Proc Natl Acad Sci U S A (1984) 2.08
Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2. Ann Oncol (2000) 2.00
Skin toxic effects of polyethylene glycol-coated liposomal doxorubicin. Arch Dermatol (2000) 1.98
Sequential growth of bacteria on crude oil. Appl Microbiol (1975) 1.96
Why do young women smoke? I. Direct and interactive effects of environment, psychological characteristics and nicotinic cholinergic receptor genes. Mol Psychiatry (2006) 1.89
Response of microbial populations to environmental disturbance. Microb Ecol (1991) 1.81
Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies. J Clin Oncol (1995) 1.77
Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump. Clin Cancer Res (2000) 1.59
Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma. Cancer (2000) 1.51
Nocardia infections in congenitally athymic (nude) mice and in other inbred mouse strains. Infect Immun (1977) 1.26
Selective delivery of doxorubicin to patients with breast carcinoma metastases by stealth liposomes. Cancer (1999) 1.21
Importance of early phase insulin secretion to intravenous glucose tolerance in subjects with type 2 diabetes mellitus. J Clin Endocrinol Metab (2001) 1.19
Tamoxifen enhances cell death in implanted MCF7 breast cancer by inhibiting endothelium growth. Cancer Res (1994) 1.18
Protein kinase C mediation of Ca(2+)-independent contractions of vascular smooth muscle. Biochem Cell Biol (1996) 1.16
The amyloid deposit in calcifying epithelial odontogenic tumor is immunoreactive for cytokeratins. Arch Pathol Lab Med (2000) 1.13
Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia. Br J Psychiatry (1996) 1.09
The implications for everyday life of incident self-reported visual decline among people over age 65 living in the community. Gerontologist (1989) 1.07
Family caregiving to the frail elderly. Annu Rev Gerontol Geriatr (1985) 1.04
Formalin treatment for massive bladder hemorrhage. Complications. Urology (1973) 1.02
Thymineless death in Bacillus subtilis: correlation between cell lysis and deoxyribonucleic acid breakdown. J Bacteriol (1974) 1.02
Social and economic incentives for family caregivers. Health Care Financ Rev (1983) 1.01
Liposomes as in vivo carriers of adriamycin: reduced cardiac uptake and preserved antitumor activity in mice. Cancer Res (1982) 1.01
Kinetics of the reactions of HO with methanol (210-351 K) and with ethanol (216-368 K). Phys Chem Chem Phys (2005) 1.00
Pharmacological studies of cisplatin encapsulated in long-circulating liposomes in mouse tumor models. Anticancer Drugs (1999) 1.00
Syndecan-4-mediated signalling. Cell Signal (2001) 1.00
Sons and daughters as caregivers to older parents: differences in role performance and consequences. Gerontologist (1985) 0.99
Response of microorganisms to an accidental gasoline spillage in an arctic freshwater ecosystem. Appl Environ Microbiol (1977) 0.99
Utility of relative cerebral blood volume mapping derived from perfusion magnetic resonance imaging in the routine follow up of brain tumors. J Neurosurg (1997) 0.98
Thalassaemia types among Kurdish Jews in Israel. Br J Haematol (1966) 0.98
The role of integrins in saphenous vein vascular smooth muscle cell migration. J Vasc Surg (1997) 0.98
Pregnancy outcome after laparoscopy or laparotomy in pregnancy. J Am Assoc Gynecol Laparosc (2003) 0.97
Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studies. Br J Cancer (1996) 0.97
Hydrogen sulfide production in the periodontal environment. J Periodontol (1973) 0.96
Comparative long-term study of the toxicities of free and liposome-associated doxorubicin in mice after intravenous administration. J Natl Cancer Inst (1986) 0.96
Breast tumors: evaluation with P-31 MR spectroscopy. Radiology (1986) 0.96
Folate-mediated tumor cell uptake of quantum dots entrapped in lipid nanoparticles. J Control Release (2007) 0.95
Enhancement of growth of a radiation-induced lymphoma by T cells from normal mice. Br J Cancer (1980) 0.95
Optimization and upscaling of doxorubicin-containing liposomes for clinical use. J Pharm Sci (1990) 0.95
Leptomeningeal metastases: rationale for systemic chemotherapy or what is the role of intra-CSF-chemotherapy? J Neurooncol (1998) 0.93
Superior therapeutic activity of liposome-associated adriamycin in a murine metastatic tumour model. Br J Cancer (1985) 0.93
Targeting of liposomes to tumor cells in vivo. Ann N Y Acad Sci (1987) 0.92
The brain venous system of the dog. Am J Anat (1971) 0.92
Alteration of blood-brain-CSF barrier in experimental meningeal carcinomatosis. A morphologic and adriamycin-penetration study. J Neurooncol (1987) 0.91
Prosthetic valve endocarditis due to Mycobacterium chelonei. J Clin Microbiol (1975) 0.91
Enhancement of antitumor activity of polyethylene glycol-coated liposomal doxorubicin with soluble and liposomal interleukin 2. Clin Cancer Res (1999) 0.90
The spatial and temporal trends of Cd, Cu, Hg, Pb and Zn in Seine River floodplain deposits (1994-2000). Sci Total Environ (2005) 0.89
Similarity of teleocidin B and phorbol ester tumour promoters in effects on membrane receptors. Nature (1981) 0.89
Pleomorphic adenoma arising in accessory salivary tissue with constriction of Stensen's duct. J Laryngol Otol (1988) 0.88
Experimental investigation of the 100 keV X-ray dose response of the high-temperature thermoluminescence in LiF:Mg,Ti (TLD-100): theoretical interpretation using the unified interaction model. Radiat Prot Dosimetry (2009) 0.87
Doxil (Caelyx): an exploratory study with pharmacokinetics in patients with hormone-refractory prostate cancer. Anticancer Drugs (2000) 0.86
Analysis of load transfer and stress distribution by an implant-supported fixed partial denture. J Prosthet Dent (1996) 0.85
Comprehensive model for the simulation of left ventricle mechanics. Part 1. Model description and simulation procedure. Med Biol Eng Comput (1986) 0.85
Comparative study of the antitumor activity of free doxorubicin and polyethylene glycol-coated liposomal doxorubicin in a mouse lymphoma model. Clin Cancer Res (1998) 0.84
Kinetics of the response of spleen cells from tumor-bearing animals in an in vivo tumor neutralization assay. Int J Cancer (1976) 0.84
Stability of liposomal doxorubicin formulations: problems and prospects. Med Res Rev (1993) 0.84
Correlation of MR imaging and histologic findings in mouse melanoma. J Magn Reson Imaging (1992) 0.83
Enhancement of adriamycin delivery to liver metastatic cells with increased tumoricidal effect using liposomes as drug carriers. Cancer Res (1983) 0.83
Comprehensive model for the simulation of left ventricle mechanics. Part 2. Implementation and results analysis. Med Biol Eng Comput (1986) 0.82
Immunohistochemical analysis of candidate gene product expression in the duodenal epithelium of children with coeliac sprue. J Clin Pathol (2001) 0.82
Rate of keratinization of the wall segment of the hoof and its relation to width and structure of the zona alba (white line) with respect to claw disease in cattle. Am J Vet Res (1996) 0.82
Cellular targets and host genes in multistage carcinogenesis. Fed Proc (1984) 0.81
Sialadenoma papilliferum of the parotid gland. J Laryngol Otol (1989) 0.81
Contrasting effects of activated and nonactivated macrophages and macrophages from tumor-bearing mice on tumor growth in vivo. J Natl Cancer Inst (1980) 0.81
Primary chondrosarcoma of the kidney. J Urol (1985) 0.81
Postnatal effects of maternal hypercortisonism on skeletal development in newborn rats. Teratology (1972) 0.81
Liposomes designed to avoid the reticuloendothelial system. Prog Clin Biol Res (1990) 0.81
Enzymatic chemical modification of human amniotic membrane and skin as a means for the preparation of biological dressing. Burns Incl Therm Inj (1982) 0.81
Separation of liposome-associated doxorubicin from non-liposome-associated doxorubicin in human plasma: implications for pharmacokinetic studies. Biochim Biophys Acta (1989) 0.81
Hyperechogenic fetal bowel and elevated serum alpha-fetoprotein: a poor fetal prognosis. Obstet Gynecol (1996) 0.80
Reduced UV-induced degradation of doxorubicin encapsulated in polyethyleneglycol-coated liposomes. Pharm Res (1999) 0.80
Thermoluminescence solid-state nanodosimetry--the peak 5A/5 dosemeter. Radiat Prot Dosimetry (2010) 0.80
Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis. Br J Pharmacol (2015) 0.80
Photolysis and OH-Initiated oxidation of glycolaldehyde under atmospheric conditions. J Phys Chem A (2005) 0.79
Stratigraphic sections, bedding sequences, and random processes. Science (1966) 0.79
The influence of physical characteristics of liposomes containing doxorubicin on their pharmacological behavior. Biochim Biophys Acta (1990) 0.79
Magnetic resonance imaging of a glomus tumor of the fingertip. J Hand Surg Am (1990) 0.79
Aggressive fibromatosis (infantile fibrosarcoma). Difficulty of diagnostic and prognostic evaluation. Clin Pediatr (Phila) (1978) 0.79
Silicon prevents post laminectomy epidural root adhesions. An experimental study in rats. Acta Neurochir (Wien) (1993) 0.78
Ventricular reentry and automaticity in myocardial infarction. Effect of size of injury. Chest (1978) 0.78
In vivo studies by magnetic resonance imaging and spectroscopy of the response to tamoxifen of MCF7 human breast cancer implanted in nude mice. Cancer Commun (1991) 0.77
Phosphate metabolites and steroid hormone receptors of benign and malignant breast tumors. A Nuclear Magnetic Resonance study. Cancer (1991) 0.77
Malignant prolactinoma. Acta Endocrinol (Copenh) (1992) 0.77
The effects of tegaserod (HTF 919) on the pharmacokinetics and pharmacodynamics of digoxin in healthy subjects. J Clin Pharmacol (2001) 0.77
Invasive colorectal adenomas: surgery versus colonoscopic polypectomy. J Surg Oncol (1990) 0.76
The recognition of premalignant change in jejunal mucosal biopsies of patients with malabsorption. J Submicrosc Cytol (1981) 0.76
Isolated primary intestinal mucormycosis. A case report. Isr J Med Sci (1974) 0.76
Effect of a chemical delivery system for dexamethasone (Dex-CDS) on peritumoral edema in an experimental brain tumor model. Pharm Res (1997) 0.76
Morphology and cytoarchitecture of the red nucleus of the domestic pig (Sus scrofa). J Comp Neurol (1970) 0.76
Benign osteonecrosis of the external ear canal. Laryngoscope (1997) 0.75
Clustering of colorectal neoplasia: characteristics of coexisting adenomas in patients with severely dysplastic polyps or invasive (malignant) polyps as compared to patients with benign adenomas or carcinomas. Postgrad Med J (1991) 0.75
A study of articular surfaces and synovial fossae of the pectoral limb of swine. Can J Comp Med (1975) 0.75
Investigation of the ionisation density dependence of the glow curve characteristics of LIF:MG,TI (TLD-100). Radiat Prot Dosimetry (2008) 0.75
Amyloidosis developing in experimental nocardia infections. Br J Exp Pathol (1977) 0.75
Clinical and immunologic study of a direct agglutination test for pregnancy (mechanisms of interference including prozoning and circulating macroglobulins). Am J Obstet Gynecol (1971) 0.75
Septic shock in obstetrics and gynecology. Postgrad Med (1969) 0.75
Conjoined twins. A report of a case of thoraco-omphalopagus. Isr J Med Sci (1971) 0.75